Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huzaifa Adamali

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Future Healthcare Journal|January 1, 2024
Animal-derived medicinal products: community representatives' views of their useSam Harding, Leonie Williams, Natalie Smith, et al.
ERJ Open Research|September 24, 2025
Ramadan fasting for patients with chronic respiratory diseases: a systematic review and consensus recommendations for healthcare professionalsFasihul Khan, Sameen Toor, Rayid Abdulqawi, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2012
Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosisHuzaifa Adamali, Michelle E Armstrong, Anne Marie McLaughlin, et al.
Future Healthcare Journal|January 1, 2024
Factoring patients' beliefs and values into decisions around anticoagulation: a community-led multi-cycle quality improvement projectNatalie Smith, Leonie Williams, Sam Harding, et al.
Trials|April 30, 2017
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trialDina Visca, Vicky Tsipouri, Letizia Mori, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2024
Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung diseaseSarah L Tansley, Fionnuala McMorrow, Caroline V Cotton, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Future Healthcare Journal|January 1, 2024
Animal-derived medicinal products: community representatives' views of their useSam Harding, Leonie Williams, Natalie Smith, et al.
ERJ Open Research|September 24, 2025
Ramadan fasting for patients with chronic respiratory diseases: a systematic review and consensus recommendations for healthcare professionalsFasihul Khan, Sameen Toor, Rayid Abdulqawi, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2012
Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosisHuzaifa Adamali, Michelle E Armstrong, Anne Marie McLaughlin, et al.
Future Healthcare Journal|January 1, 2024
Factoring patients' beliefs and values into decisions around anticoagulation: a community-led multi-cycle quality improvement projectNatalie Smith, Leonie Williams, Sam Harding, et al.
Trials|April 30, 2017
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trialDina Visca, Vicky Tsipouri, Letizia Mori, et al.
Thorax|January 17, 2013
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosisCarmel J Stock, Hiroe Sato, Carmen Fonseca, et al.
Clinical Immunology (Orlando, Fla.)|April 4, 2024
Identification of connective tissue disease autoantibodies and a novel autoantibody anti-annexin A11 in patients with "idiopathic" interstitial lung diseaseSarah L Tansley, Fionnuala McMorrow, Caroline V Cotton, et al.
The Lancet. Respiratory Medicine|September 2, 2018
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialDina Visca, Letizia Mori, Vicky Tsipouri, et al.
American Journal of Respiratory and Critical Care Medicine|October 2, 2020
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter StudyThomas M Drake, Annemarie B Docherty, Ewen M Harrison, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
Pageof 3